Article | Published:

Reprogramming human endothelial cells to haematopoietic cells requires vascular induction

Nature volume 511, pages 312318 (17 July 2014) | Download Citation



Generating engraftable human haematopoietic cells from autologous tissues is a potential route to new therapies for blood diseases. However, directed differentiation of pluripotent stem cells yields haematopoietic cells that engraft poorly. Here, we have devised a method to phenocopy the vascular-niche microenvironment of haemogenic cells, thereby enabling reprogramming of human endothelial cells into engraftable haematopoietic cells without transition through a pluripotent intermediate. Highly purified non-haemogenic human umbilical vein endothelial cells or adult dermal microvascular endothelial cells were transduced with the transcription factors FOSB, GFI1, RUNX1 and SPI1 (hereafter referred to as FGRS), and then propagated on serum-free instructive vascular niche monolayers to induce outgrowth of haematopoietic colonies containing cells with functional and immunophenotypic features of multipotent progenitor cells (MPPs). These endothelial cells that have been reprogrammed into human MPPs (rEC-hMPPs) acquire colony-forming-cell potential and durably engraft into immune-deficient mice after primary and secondary transplantation, producing long-term rEC-hMPP-derived myeloid (granulocytic/monocytic, erythroid, megakaryocytic) and lymphoid (natural killer and B cell) progenies. Conditional expression of FGRS transgenes, combined with vascular induction, activates endogenous FGRS genes, endowing rEC-hMPPs with a transcriptional and functional profile similar to that of self-renewing MPPs. Our approach underscores the role of inductive cues from the vascular niche in coordinating and sustaining haematopoietic specification and may prove useful for engineering autologous haematopoietic grafts to treat inherited and acquired blood disorders.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


Primary accessions

Gene Expression Omnibus

Data deposits

Data have been deposited in the GEO database under accession number GSE57662.


  1. 1.

    et al. Human ESC-derived hemogenic endothelial cells undergo distinct waves of endothelial to hematopoietic transition. Blood 121, 770–780 (2013)

  2. 2.

    , , & Defining the path to hematopoietic stem cells. Nature Biotechnol. 31, 416–418 (2013)

  3. 3.

    et al. Identification of the hemogenic endothelial progenitor and its direct precursor in human pluripotent stem cell differentiation cultures. Cell Rep. 2, 553–567 (2012)

  4. 4.

    et al. Induction of a hemogenic program in mouse fibroblasts. Cell Stem Cell 13, 205–218 (2013)

  5. 5.

    et al. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 468, 521–526 (2010)

  6. 6.

    , , & Stepwise reprogramming of B cells into macrophages. Cell 117, 663–676 (2004)

  7. 7.

    , & Reprogramming of embryonic human fibroblasts into fetal hematopoietic progenitors by fusion with human fetal liver CD34+ cells. PLoS ONE 6, e18265 (2011)

  8. 8.

    et al. Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration. Dev. Cell 26, 204–219 (2013)

  9. 9.

    et al. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature 468, 310–315 (2010)

  10. 10.

    et al. Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization. Cell 147, 539–553 (2011)

  11. 11.

    et al. Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell 6, 251–264 (2010)

  12. 12.

    et al. Development of a vascular niche platform for expansion of repopulating human cord blood stem and progenitor cells. Blood 120, 1344–1347 (2012)

  13. 13.

    et al. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell 4, 263–274 (2009)

  14. 14.

    et al. Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells. Nature Cell Biol. 12, 1046–1056 (2010)

  15. 15.

    et al. Endothelial jagged-1 is necessary for homeostatic and regenerative hematopoiesis. Cell Rep. 4, 1022–1034 (2013)

  16. 16.

    et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nature Med. 10, 64–71 (2004)

  17. 17.

    , , & Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 481, 457–462 (2012)

  18. 18.

    et al. Tie2+ bone marrow endothelial cells regulate hematopoietic stem cell regeneration following radiation injury. Stem Cells 31, 327–337 (2013)

  19. 19.

    & Hematopoiesis: an evolving paradigm for stem cell biology. Cell 132, 631–644 (2008)

  20. 20.

    & Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 86, 897–906 (1996)

  21. 21.

    et al. Runx1 expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo. Immunity 16, 661–672 (2002)

  22. 22.

    , & Overcoming obstacles in the search for the site of hematopoietic stem cell emergence. Cell Stem Cell 3, 583–586 (2008)

  23. 23.

    , & Continuous single-cell imaging of blood generation from haemogenic endothelium. Nature 457, 896–900 (2009)

  24. 24.

    et al. Early dynamic fate changes in haemogenic endothelium characterized at the single-cell level. Nature Commun. 4, 2924 (2013)

  25. 25.

    et al. The emergence of hematopoietic stem cells is initiated in the placental vasculature in the absence of circulation. Cell Stem Cell. 2, 252–263 (2008)

  26. 26.

    , , , & Mouse extraembryonic arterial vessels harbor precursors capable of maturing into definitive HSCs. Blood 122, 2338–2345 (2013)

  27. 27.

    et al. Fate tracing reveals the endothelial origin of hematopoietic stem cells. Cell Stem Cell 3, 625–636 (2008)

  28. 28.

    et al. Erythroid/myeloid progenitors and hematopoietic stem cells originate from distinct populations of endothelial cells. Cell Stem Cell 9, 541–552 (2011)

  29. 29.

    et al. GFI1 and GFI1B control the loss of endothelial identity of hemogenic endothelium during hematopoietic commitment. Blood 120, 314–322 (2012)

  30. 30.

    et al. Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Nature 431, 1002–1007 (2004)

  31. 31.

    et al. Generation of a functional and durable vascular niche by the adenoviral E4ORF1 gene. Proc. Natl Acad. Sci. USA 105, 19288–19293 (2008)

  32. 32.

    et al. Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion. Blood 84, 10–19 (1994)

  33. 33.

    et al. Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood 86, 3353–3363 (1995)

  34. 34.

    , , , & Hemogenic endothelial progenitor cells isolated from human umbilical cord blood. Stem Cells 25, 2770–2776 (2007)

  35. 35.

    et al. Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFβ inhibition is Id1 dependent. Nature Biotechnol. 28, 161–166 (2010)

  36. 36.

    et al. Efficient direct reprogramming of mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression. Cell 151, 559–575 (2012)

  37. 37.

    , & Establishment of a normal hematopoietic and leukemia stem cell hierarchy. Cold Spring Harb. Symp. Quant. Biol. 73, 439–449 (2008)

  38. 38.

    et al. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 333, 218–221 (2011)

  39. 39.

    , , , & Knockdown of Pu.1 by small interfering RNA in CD34+ embryoid body cells derived from mouse ES cells turns cell fate determination to pro-B cells. Proc. Natl Acad. Sci. USA 102, 13236–13241 (2005)

  40. 40.

    et al. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5. Nature Immunol. 9, 203–215 (2008)

  41. 41.

    et al. Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches. Cell Stem Cell 3, 85–98 (2008)

  42. 42.

    et al. Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors. Cell Stem Cell 13, 459–470 (2013)

  43. 43.

    et al. Hemogenic endothelial cell specification requires c-Kit, Notch signaling, and p27-mediated cell-cycle control. Dev. Cell 27, 504–515 (2013)

Download references


V.M.S. is supported by Empire State Stem Cell Board (ESSCB) and New York State Department of Health (NYSDH C026878). S.R. is supported by Ansary Stem Cell Institute (ASCI), HHMI, ESSCB/NYSDH (C024180, C026438, C026878, C028117), NHLBI (R01HL097797, R01HL119872, U01 HL099997), NIDDK (R01DK095039) , NCI (U54CA163167), Qatar National Priorities Research Foundation grant NPRP08-663-3-140 and the Qatar Foundation BioMedical Research Program. J.M.S. is supported by grants from NCI (CA159175 and CA163167), NHLBI (HL119872 and HL055748), Starr Foundation and a Leukemia & Lymphoma Society Scholar award. J.M.B. is supported by an American Society of Hematology Scholar Award, NHLBI U01-HL099997 and Angiocrine Bioscience and ASCI. We acknowledge the contribution of J. Z. Xiang and Agnes J. Viale for enabling and executing molecular profiling, and E. Gars for technical support. We appreciate W. Schachterle for recommendations and edits of the manuscript.

Author information


  1. Ansary Stem Cell Institute, Department of Genetic Medicine, and Howard Hughes Medical Institute, Weill Cornell Medical College, New York, New York 10065, USA

    • Vladislav M. Sandler
    • , Raphael Lis
    • , Ying Liu
    • , Alon Kedem
    • , Daylon James
    • , Jason M. Butler
    •  & Shahin Rafii
  2. Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medical College, New York, New York 10065, USA

    • Raphael Lis
    • , Alon Kedem
    •  & Daylon James
  3. HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College, New York, New York 10065, USA

    • Olivier Elemento
  4. Department of Medicine, Hematology-Oncology, Weill Cornell Medical College and the New York Presbyterian Hospital, New York, New York 10065, USA

    • Joseph M. Scandura


  1. Search for Vladislav M. Sandler in:

  2. Search for Raphael Lis in:

  3. Search for Ying Liu in:

  4. Search for Alon Kedem in:

  5. Search for Daylon James in:

  6. Search for Olivier Elemento in:

  7. Search for Jason M. Butler in:

  8. Search for Joseph M. Scandura in:

  9. Search for Shahin Rafii in:


V.M.S. and S.R. conceived and designed the project, performed experiments, analysed the data and wrote the manuscript. R.L., Y.L. and J.M.B. performed experiments, interpreted and analysed data. J.M.S. interpreted, analysed data and wrote the manuscript. D.J., O.E. and A.K. performed the experiments and analysed the data. All authors commented on the paper.

Competing interests

S.R. is the founder of and consultant to Angiocrine Bioscience New York, NY. J.M.B. received sponsored research funding from Angiocrine Bioscience New York, NY.

Corresponding author

Correspondence to Shahin Rafii.

Extended data

About this article

Publication history





Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.